Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Integrated BioPharma Inc. (INBP) had Debt to Capital Ratio of 0.01 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$12.69M |
|
$0.12M |
|
$11.67M |
|
$1.02M |
|
$12.53M |
|
$0.16M |
|
$0.03M |
|
$0.20M |
|
$0.20M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$0.12M |
|
$0.16M |
|
$0.49M |
|
31.06M |
|
31.42M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$19.62M |
|
$1.82M |
|
$5.92M |
|
$25.54M |
|
$4.76M |
|
$0.10M |
|
$0.29M |
|
$5.05M |
|
$20.49M |
|
$20.49M |
|
$20.49M |
|
31.06M |
|
| Cash Flow Statement Financials | |
$1.30M |
|
$-0.17M |
|
$-0.01M |
|
$3.62M |
|
$4.73M |
|
$1.12M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.12 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.01 |
0.01 |
|
8.03% |
|
1.28% |
|
1.28% |
|
-- |
|
1.54% |
|
0.97% |
|
$1.13M |
|
-- |
|
-- |
|
-- |
|
0.50 |
|
1.11 |
|
3.19 |
|
28.25 |
|
0.60% |
|
0.60% |
|
0.48% |
|
0.60% |
|
$0.66 |
|
$0.04 |
|
$0.04 |
|